Viatris (VTRS) Sɔɔtɔ Fɔrɛkɛst
Viatris
AI forecast: VTRS
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
On November 16, 2020, Viatris Inc. was formed through the successful merger of Mylan N.V. and Pfizer’s Upjohn business unit. Leveraging the heritage of these two complementary businesses, Viatris possesses scientific, manufacturing, and logistics infrastructure, as well as significant expertise in regulatory, medical, and commercial matters, enabling it to provide patients with quality medicines in more than 165 countries.
